Top Sell
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| AEterna Zentaris Inc. | 2 | 20 | 0 | 1 | €1.87 | €8.51 | 355.096% |
| Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |
| Alterity Therapeutics Ltd. ADR | 0 | 1 | 0 | 0 | €0.66 | - | - |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.54 | - | - |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 3 | 0 | €18.97 | €54.98 | 189.908% |
| Aspira Womens Health Inc. | 1 | 1 | 0 | 0 | €0.64 | €4.99 | 680.063% |
| Atara Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €0.37 | - | - |
| Bayer AG ADR | 1 | 1 | 1 | 0 | €6.75 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Biogen Inc. | 53 | 2 | 3 | 0 | €177.30 | €280.50 | 58.206% |
| BioLine RX Ltd ADR | 0 | 1 | 0 | 0 | €0.60 | - | - |
| Bluebird Bio Inc. | 7 | 6 | 0 | 0 | €0.42 | €5.47 | 1203.429% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 0 | 1 | 0 | 0 | €1.57 | - | - |
| Bristol-Myers Squibb | 6 | 3 | 1 | 1 | €44.14 | €61.40 | 39.112% |
| Cara Therapeutics Inc. | 10 | 7 | 0 | 2 | €0.25 | €4.61 | 1738.566% |
| Carbylan Therapeutics Inc | 0 | 1 | 0 | 0 | €9.70 | - | - |
| Cardiff Oncology Inc. | 2 | 4 | 1 | 0 | €2.31 | - | - |
| CareRx Corp. | 0 | 1 | 0 | 0 | €1.07 | - | - |
| Carl Zeiss Meditec AG | 2 | 1 | 0 | 0 | €56.80 | €122.00 | 114.789% |
| Cellectar BioSciences Inc. | 4 | 4 | 0 | 0 | €1.85 | €14.75 | 697.449% |
| Coherus Bioscien. | 0 | 2 | 0 | 0 | €0.95 | - | - |
| Cyclacel Pharmaceuticals Inc. | 2 | 9 | 0 | 1 | €0.22 | €14.66 | 6565.591% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.07 | €50.00 | 4586.036% |
| D.Western Therapeutics Institute Inc | 0 | 1 | 0 | 0 | €0.36 | - | - |